Keyword: Merck & Co.

News

US Merck Fails to Transfer all Talc Liability to Bayer

14.04.2023 -

A move by US drugmaker Merck & Co. to have Bayer assume all liability for lawsuits alleging that the talc-based Dr. Scholl's foot powder causes cancer has failed, at...

News

Proxygen and US Merck Collaborate on Molecular Glue Degraders

12.04.2023 -

Austrian biotech Proxygen has announced a multi-year collaboration and license agreement with US drugmaker Merck & Co to identify and develop molecular glue degraders...

News

US Drugmaker Merck & Co. to Add Jobs in Ireland

07.09.2022 -

US drugmaker Merck & Co. plans to add 100 new jobs as part of an expansion project at its site in Carlow, Ireland, which opened in 2008 as the company’s first vaccines...

News

Pfizer to Spend $120 Million on US Paxlovid Buildup

14.06.2022 -

Pfizer will invest $120 million at its plant in Kalamazoo, Michigan, to support US production of its Paxlovid (nirmatrelvir) oral antiviral treatment for Covid-19. The...

News

FDA Greenlights GSK’s MMR Vaccine

07.06.2022 -

The US Food and Drug Administration (FDA) has greenlit GSK’s Priorix-branded GSK’s mumps and rubella vaccine (MMR) for people 12 months and older. It is only the second...

News

Merck & Co Collaborates with Curve

02.03.2022 -

US pharma group Merck & Co is collaborating with Curve Therapeutics, a privately-held UK biotech that has developed a proprietary functional drug discovery platform...

News

FDA Advisory Panel Narrowly Votes for Lagevrio EUA

03.12.2021 -

With a vote of 13 to 10, the Antimicrobial Drugs Advisory Committee, an advisory panel to the US Food and Drug Administration, narrowly decided to to recommend emergency...

News

Pfizer Lifts Paxlovid Capacity Before EUA is Granted

01.12.2021 -

In response to new data published by rival Merck that downgrade earlier efficacy forecasts for its for Covid-19 oral antiviral treatment, Pfizer has announced will...